BNP Paribas Financial Markets Sells 3,561 Shares of HealthEquity, Inc. (NASDAQ:HQY)

BNP Paribas Financial Markets reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,876 shares of the company's stock after selling 3,561 shares during the period. BNP Paribas Financial Markets' holdings in HealthEquity were worth $1,619,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of HQY. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity in the 4th quarter worth about $26,000. Transce3nd LLC bought a new position in shares of HealthEquity in the 4th quarter worth about $29,000. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC bought a new position in shares of HealthEquity in the 4th quarter worth about $39,000. Finally, UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HQY shares. Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday, April 11th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp decreased their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $111.75.

HealthEquity Price Performance

HQY stock opened at $98.23 on Monday. The company has a market capitalization of $8.50 billion, a P/E ratio of 90.12, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The business has a 50-day simple moving average of $87.88 and a two-hundred day simple moving average of $97.12.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.